Pegvisomant in acromegaly: an update

ConclusionsPEG increasingly appears to be an effective and safe medical option for many patients not controlled by SRL but its use still needs to be optimized.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research